Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas-Reference-Cited by-同舟云学术

Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas

Published:2012-04-12 Issue:4 Volume:7 Page:e33813
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kluk Michael J.,Chapuy Bjoern,Sinha Papiya,Roy Alyssa,Cin Paola Dal,Neuberg Donna S.,Monti Stefano,Pinkus Geraldine S.,Shipp Margaret A.,Rodig Scott J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Molecular biology of Burkitt's lymphoma.;JL Hecht;J Clin Oncol,2000

2. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.;KJ Savage;Blood,2009

3. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.;M Hummel;N Engl J Med,2006

4. Clinical significance and prognosis of MYC translocation in diffuse large B-cell lymphoma.;HW Zhang;Hematol Oncol,2011

5. Molecular diagnosis of Burkitt's lymphoma.;SS Dave;N Engl J Med,2006

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemistry-based investigation of MYC, BCL2, and Ki-67 protein expression and their clinical impact in diffuse large B-cell lymphoma in upper Northern Thailand;PLOS ONE;2024-07-22

2. Prognostic significance of copy number gains of MYC detected by fluorescence in situ hybridization in large B-cell lymphoma;Leukemia & Lymphoma;2023-10-05

3. MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients;Cancer Medicine;2023-08-28

4. Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma;eJHaem;2022-12-07

5. Anti-myelocytomatosis tag antibody detects myelocytomatosis oncogene expression in Burkitt lymphoma;South African Journal of Oncology;2022-12-05